GO:0070782 phosphatidylserine exposure on apoptotic cell surface: Apoptotic Eat-Me Signal, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070782 describes the phospholipid scrambling process that externalizes phosphatidylserine (PS) to the outer leaflet of the plasma membrane during apoptosis.
• PS exposure is the canonical 'eat-me' signal that enables recognition and engulfment of apoptotic cells by phagocytes.
• Annexin V binding to externalized PS is the basis for the most widely used flow cytometric apoptosis assay.
• PS exposure is distinct from necrosis, necroptosis, and ferroptosis and can be discriminated by microscopy and flow cytometry.
• Viruses exploit PS-mediated apoptotic mimicry to enhance entry and immune evasion.
• PS externalization also regulates non-apoptotic processes such as osteoclast precursor fusion and oral tolerance.
Description
Phosphatidylserine (PS) is an aminophospholipid normally restricted to the inner leaflet of the plasma membrane. During apoptosis, PS is rapidly externalized to the outer leaflet, where it serves as a molecular flag for phagocytic recognition. This process is formally described by the Gene Ontology term GO:0070782, phosphatidylserine exposure on apoptotic cell surface, defined as a phospholipid scrambling process that results in the appearance of PS on the outer leaflet of the plasma membrane of an apoptotic cell, acting as an 'eat-me' signal for engulfing cells. The term captures a critical step in the apoptotic program that bridges cell death to immune clearance. Researchers study PS exposure to quantify apoptosis, to understand phagocyte recognition, and to dissect the molecular machinery of phospholipid scrambling. Because PS externalization is a hallmark of early apoptosis, it is widely used as a readout in drug discovery, immunology, and cancer biology. The process is also co-opted in non-apoptotic contexts, including osteoclast fusion and immune tolerance, underscoring its broad biological significance.
phosphatidylserine exposure on apoptotic cell surface At A Glance
| GO ID | GO:0070782 |
|---|---|
| GO term | phosphatidylserine exposure on apoptotic cell surface |
| Ontology | biological_process |
| Synonym | externalization of phosphatidylserine |
| Major function | Phospholipid scrambling that externalizes phosphatidylserine to the outer leaflet of the plasma membrane during apoptosis, serving as an 'eat-me' signal for phagocytes |
| Definition source | QuickGO definition based on published literature |
| Related process | Apoptotic cell clearance / efferocytosis |
| Key assay | Annexin V flow cytometry |
| Disease relevance | Cancer, autoimmunity, viral infection, and bone homeostasis |
What Is GO:0070782?
GO:0070782 is a biological process term describing the phospholipid scrambling event that moves phosphatidylserine from the inner to the outer leaflet of the plasma membrane in an apoptotic cell. The exposed PS acts as an 'eat-me' signal for engulfing cells, and the exposure is mediated by a phospholipid scramblase activity.
Why Is phosphatidylserine exposure on apoptotic cell surface Important in Cell Biology?
PS exposure on the apoptotic cell surface is a central mechanism linking programmed cell death to immune surveillance and tissue homeostasis. It is the most widely used marker for early apoptosis in both research and clinical settings. Defects in PS exposure or recognition contribute to autoimmunity, chronic inflammation, and impaired clearance of dying cells. Moreover, pathogens and tumor cells exploit PS signaling for immune evasion, making this pathway a target for therapeutic intervention.
• Provides the gold-standard marker for early apoptosis detection via Annexin V binding.
• Enables phagocytic recognition and clearance of apoptotic cells, preventing secondary necrosis and inflammation.
• Distinguishes apoptosis from necrosis, necroptosis, and ferroptosis in cell death assays.
• Regulates osteoclast precursor fusion and bone remodeling.
• Contributes to immune tolerance mechanisms such as oral tolerance.
• Is exploited by viruses for apoptotic mimicry and enhanced entry.
• Plays a role in platelet activation and lipidomic changes.
• Serves as a target for cancer immunotherapy and anti-inflammatory strategies.
• Involved in clearance of dying cells during development and tissue repair.
• Provides a readout for drug-induced apoptosis in preclinical screens.
What Happens During phosphatidylserine exposure on apoptotic cell surface?
Initiation of apoptosis and lipid asymmetry loss
In simple terms: When a cell receives a death signal, it begins to lose the normal asymmetric distribution of lipids in its membrane.
Apoptotic stimuli trigger signaling cascades that lead to the activation of executioner caspases and downstream effectors. A key early event is the loss of plasma membrane phospholipid asymmetry, which is normally maintained by ATP-dependent flippases and supported by scramblases and floppases. This loss of asymmetry precedes other apoptotic hallmarks such as DNA fragmentation and allows PS to move to the outer leaflet.
Phospholipid scrambling and PS externalization
In simple terms: Specialized scramblase proteins rapidly flip phosphatidylserine from the inside to the outside of the cell membrane.
Phospholipid scramblases catalyze the bidirectional movement of phospholipids across the lipid bilayer, dissipating lipid asymmetry. During apoptosis, caspase-dependent activation of scramblases such as XKR8 (XK related 8) and TMEM16F (ANO6) leads to rapid PS exposure on the cell surface. This scrambling activity is calcium-dependent for some scramblases and is tightly regulated to ensure PS appears only on apoptotic cells.
Recognition by phagocytes and 'eat-me' signaling
In simple terms: The exposed phosphatidylserine acts like a flag that tells scavenger cells to engulf and digest the dying cell.
Externalized PS is recognized by phagocyte receptors either directly or via bridging molecules such as MFG-E8 and Gas6. This interaction triggers cytoskeletal rearrangements and engulfment of the apoptotic cell, a process known as efferocytosis. PS-mediated recognition is essential for silent clearance of dying cells and prevents the release of inflammatory contents.
Downstream consequences and non-apoptotic roles
In simple terms: Phosphatidylserine exposure is not only for cell death; it also helps in bone formation and immune tolerance.
Beyond apoptosis, PS exposure on the cell surface regulates osteoclast precursor fusion, a process required for bone resorption. PS also plays a role in oral tolerance, where it contributes to immune suppression and tolerance induction. Additionally, viruses can mimic apoptotic cells by displaying PS to enhance entry and evade immune detection. These diverse roles highlight the pleiotropic functions of PS externalization.
Key Genes Involved in GO:0070782 phosphatidylserine exposure on apoptotic cell surface
The following genes and proteins are experimentally implicated in phosphatidylserine exposure on the apoptotic cell surface and its downstream recognition.
| Gene | Major Role | Research Relevance |
|---|---|---|
| XKR8 | Phospholipid scramblase that externalizes PS during apoptosis | Core executioner of PS exposure; knockout reduces PS externalization |
| ANO6 (TMEM16F) | Calcium-dependent scramblase contributing to PS exposure | Involved in apoptotic and non-apoptotic scrambling |
| CASP3 | Executioner caspase that activates scramblases | Apoptosis effector; required for PS exposure |
| CASP7 | Executioner caspase cooperating in apoptosis | Redundant with CASP3 in some contexts |
| BAX | Pro-apoptotic BCL-2 family member | Mitochondrial outer membrane permeabilization upstream of PS exposure |
| BAK1 | Pro-apoptotic BCL-2 family member | Cooperates with BAX in apoptosis initiation |
| MFGE8 | Bridging molecule that binds PS and promotes phagocytosis | Enhances efferocytosis; knockout impairs clearance |
| GAS6 | Ligand for TAM receptors that binds PS | Facilitates phagocyte recognition of apoptotic cells |
| AXL | TAM family receptor tyrosine kinase | Mediates PS-dependent engulfment and immune regulation |
| MERTK | TAM family receptor tyrosine kinase | Critical for retinal and macrophage efferocytosis |
| ITGB3 | Integrin subunit involved in PS recognition | Contributes to phagocytic binding |
| CD36 | Scavenger receptor that recognizes PS | Participates in apoptotic cell clearance |
| STAB1 | Stabilin receptor for PS | Mediates clearance of apoptotic cells |
| TIMD4 | PS receptor on macrophages | Involved in efferocytosis and immune tolerance |
| RAC1 | Small GTPase regulating cytoskeletal rearrangement during engulfment | Required for phagocytic cup formation |
| ATP8A1 | Flippase that maintains PS asymmetry | Loss of function contributes to PS exposure |
| ATP11A | Flippase inactivated during apoptosis | Caspase cleavage leads to PS externalization |
| ATP11C | Flippase inactivated during apoptosis | Caspase cleavage leads to PS externalization |
How Is phosphatidylserine exposure on apoptotic cell surface Regulated?
PS exposure is regulated by the balance between flippase and scramblase activities. During apoptosis, caspases cleave and inactivate flippases such as ATP11A and ATP11C, while simultaneously activating scramblases like XKR8 through caspase-mediated cleavage. Calcium influx can activate TMEM16F scramblase in non-apoptotic contexts. Additionally, the expression and activity of PS recognition receptors on phagocytes, such as TAM receptors, modulate the efficiency of clearance. In non-apoptotic settings, PS exposure is tightly controlled to avoid inappropriate immune activation, as seen in osteoclast fusion and oral tolerance.
phosphatidylserine exposure on apoptotic cell surface and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| XKR8 | Cancer, autoimmunity | XKR8 knockout cell lines to assess PS exposure and efferocytosis |
| MFGE8 | Autoimmune disease, impaired clearance | MFGE8 knockout mice or macrophages |
| AXL | Cancer, viral infection | AXL overexpression or knockout in cancer cell lines |
| ANO6 | Bone disorders, bleeding | ANO6 point mutations to study calcium-dependent scrambling |
| ATP11A | Autoimmunity, neurological disorders | ATP11A knockout to induce PS exposure |
Cancer and immune evasion
Tumor cells often display PS on their surface, mimicking apoptotic cells to evade immune detection and promote immunosuppression. This PS exposure can inhibit anti-tumor immune responses and is associated with poor prognosis. Targeting PS or its receptors is being explored as an immunotherapeutic strategy.
Autoimmunity and chronic inflammation
Defective clearance of apoptotic cells due to impaired PS exposure or recognition can lead to secondary necrosis and release of autoantigens, contributing to autoimmune diseases such as systemic lupus erythematosus. Proper PS-mediated efferocytosis is essential for maintaining self-tolerance.
Viral infections
Many viruses incorporate PS into their envelopes or induce PS exposure on infected cells to mimic apoptotic bodies, enhancing viral entry and immune evasion. This phenomenon, known as apoptotic mimicry, is observed in viruses such as Ebola, dengue, and vaccinia.
Bone disorders
PS exposure on osteoclast precursors is required for their fusion into multinucleated osteoclasts. Dysregulation of this process can lead to bone diseases such as osteoporosis or osteopetrosis.
From phosphatidylserine exposure on apoptotic cell surface-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate PS exposure during apoptosis? | CRISPR knockout of candidate gene followed by Annexin V flow cytometry |
| Does a specific point mutation in a scramblase affect PS externalization? | CRISPR point mutation knock-in of the catalytic residue |
| Can a tagged scramblase be used to monitor localization? | Knock-in of fluorescent or epitope tag at endogenous locus |
| Does overexpression of a flippase reduce PS exposure? | Overexpression of ATP11A or ATP11C in apoptotic cells |
| Which genes are essential for efferocytosis? | CRISPR library screening in phagocytes with PS-coated beads |
| Can PS exposure be used as a biomarker for drug response? | Patient-derived cells treated with chemotherapeutics and Annexin V staining |
How to Study the phosphatidylserine exposure on apoptotic cell surface Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Annexin V flow cytometry | Externalized PS on apoptotic cells | Apoptosis quantification in drug screens |
| Fluorescence microscopy | Spatial distribution of PS | Discriminating cell death modes |
| CRISPR knockout screening | Genes required for PS exposure | Discovery of novel regulators |
| Lipidomics (mass spectrometry) | PS species and membrane asymmetry | Platelet and cell membrane studies |
| Phagocytosis assays | Engulfment of PS-positive cells | Efferocytosis research |
| Immunoblotting | Cleavage of flippases and scramblases | Apoptotic signaling |
| Calcium imaging | Intracellular calcium flux | Scramblase activation |
| CRISPR activation (CRISPRa) | Overexpression of candidate genes | Gain-of-function studies |
Flow cytometry with Annexin V
Annexin V conjugated to fluorophores binds externalized PS with high affinity, allowing quantification of apoptotic cells by flow cytometry. This method is rapid, quantitative, and widely used to detect early apoptosis.
Microscopy-based assays
Fluorescence microscopy using Annexin V or PS-specific probes enables spatial visualization of PS exposure on the cell surface. It can discriminate apoptosis from necrosis and other cell death modalities when combined with viability dyes.
CRISPR screening and functional genomics
Genome-wide CRISPR knockout or activation screens coupled with Annexin V sorting can identify novel regulators of PS exposure. Such screens have uncovered components of the scrambling machinery and efferocytosis pathways.
Proteomics and lipidomics
Mass spectrometry-based lipidomics can quantify PS species on the outer leaflet, while proteomics can identify PS-binding proteins. These approaches provide mechanistic insights into PS externalization and recognition.
How CRISPR Can Be Used to Study GO:0070782 phosphatidylserine exposure on apoptotic cell surface
Knockout
CRISPR knockout of scramblases such as XKR8 or flippases like ATP11A can abolish or enhance PS exposure, respectively. These models are essential to establish causality and to study downstream effects on efferocytosis.
Point Mutation
Introducing point mutations in catalytic residues of scramblases or caspase cleavage sites in flippases allows precise dissection of their roles in PS externalization. Such models can reveal calcium-binding sites or regulatory phosphorylation sites.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) at endogenous loci enables real-time imaging of scramblase trafficking and activation during apoptosis. Tagged knock-in models also facilitate proteomic interaction studies.
Overexpression
Overexpression of PS recognition receptors or bridging molecules can enhance efferocytosis and modulate immune responses. Conversely, overexpression of flippases can suppress PS exposure and delay apoptosis.
How EDITGENE Supports phosphatidylserine exposure on apoptotic cell surface Research
Researchers studying phosphatidylserine exposure on apoptotic cell surface-related genes often need to determine whether a candidate gene is causally involved in PS externalization, recognition, or downstream clearance. EDITGENE provides comprehensive CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for phosphatidylserine exposure on apoptotic cell surface research.
Frequently Asked Questions About phosphatidylserine exposure on apoptotic cell surface
What is phosphatidylserine exposure on apoptotic cell surface?
It is the process by which phosphatidylserine, a phospholipid normally inside the cell, flips to the outer surface during apoptosis, acting as an 'eat-me' signal for phagocytes.
What is GO:0070782?
GO:0070782 is the Gene Ontology term for phosphatidylserine exposure on apoptotic cell surface, a biological process describing phospholipid scrambling that externalizes PS.
What genes are involved in phosphatidylserine exposure?
Key genes include XKR8, ANO6 (TMEM16F), CASP3, CASP7, BAX, BAK1, ATP11A, ATP11C, and recognition molecules like MFGE8 and GAS6.
How is phosphatidylserine exposure measured?
The most common method is Annexin V flow cytometry, which binds externalized PS and detects early apoptosis.
Why is phosphatidylserine exposure important in cancer?
Tumor cells often expose PS to mimic apoptotic cells, evading immune detection and promoting immunosuppression.
What is the role of phosphatidylserine in viral infection?
Viruses can incorporate PS into their envelopes or induce PS exposure to enhance entry and immune evasion, a process called apoptotic mimicry.
Can phosphatidylserine exposure be used to distinguish apoptosis from necrosis?
Yes, PS exposure is a hallmark of apoptosis and can be discriminated from necrosis, necroptosis, and ferroptosis using Annexin V combined with other markers.
What is the 'eat-me' signal in apoptosis?
Phosphatidylserine exposed on the apoptotic cell surface is the primary 'eat-me' signal recognized by phagocytes.
How does phosphatidylserine exposure relate to osteoclasts?
PS exposure on osteoclast precursors regulates their fusion into multinucleated osteoclasts, important for bone resorption.
What CRISPR models are available to study phosphatidylserine exposure?
EDITGENE offers knockout, point mutation, knock-in, overexpression, and library screening services for genes involved in PS exposure and recognition.
Conclusion
Phosphatidylserine exposure on the apoptotic cell surface (GO:0070782) is a fundamental biological process that bridges cell death to immune clearance. Its precise regulation by scramblases and flippases ensures that PS appears only on dying cells, where it serves as an 'eat-me' signal for phagocytes. Dysregulation of this process contributes to cancer, autoimmunity, viral pathogenesis, and bone disorders. Understanding the molecular players and their regulation offers opportunities for therapeutic intervention. EDITGENE provides a comprehensive suite of CRISPR services to dissect this pathway and accelerate discovery.
References
- 1. Vermes I et al.. 1995. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V.. J Immunol Methods 184(1):39-51 PMID: 7622868
- 2. Nagata S et al.. 2016. Exposure of phosphatidylserine on the cell surface.. Cell Death Differ 23(6):952-61 PMID: 26891692
- 3. Nguyen NH et al.. 2023. Phosphatidylserine-mediated oral tolerance.. Cell Immunol 384:104660 PMID: 36586393
- 4. Costigan A et al.. 2023. Discriminating Between Apoptosis, Necrosis, Necroptosis, and Ferroptosis by Microscopy and Flow Cytometry.. Curr Protoc 3(12):e951 PMID: 38112058
- 5. Verma SK et al.. 2018. Cell-surface phosphatidylserine regulates osteoclast precursor fusion.. J Biol Chem 293(1):254-270 PMID: 29101233
- 6. Amara A et al.. 2015. Viral apoptotic mimicry.. Nat Rev Microbiol 13(8):461-9 PMID: 26052667
- 7. Segawa K et al.. 2015. An Apoptotic 'Eat Me' Signal: Phosphatidylserine Exposure.. Trends Cell Biol 25(11):639-650 PMID: 26437594
- 8. Dolegowska B et al.. 2012. Platelet lipidomic.. J Biol Regul Homeost Agents 26(2 Suppl 1):23S-33S PMID: 23648196
